
    
      Assessment will be done for maternal serum anti-beta 2 glycoprotein 1 antibodies and
      anticardiolipin antibodies in cases of preeclampsia after 32 weeks of pregnancy. In addition,
      fetal Doppler changes will be assessed.
    
  